CDC Again Advises against Nasal Spray Flu Vaccine
June 28, 2017 | Risk Management News
The Centers for Disease Control and Prevention (CDC) advised against the use of FluMist, the nasal spray flu vaccine (i.e., live attenuated influenza vaccine), for the 2017-2018 season, according to a June 21, 2017, article on CNN.com. CDC issued the recommendation at a meeting of its Advisory Committee on Immunization Practices on June 21 and 22. At the 2016 meeting, CDC introduced a study that showed the nasal spray vaccine to be ineffective (see HRC Alerts, June 29, 2016: Nasal Spray Vaccine Should Not Be Used in the 2016-2017 Flu Season, Says CDC). Although the nasal spray vaccine is not recommended, it is still approved by the U.S. Food and Drug Administration for patients between the ages of 2 and 49.